The University of Victoria Genome B.C. Proteomics Centre has been providing mass spectrometry services that have allowed revolutionary biomedical and life science research to happen for over three decades, but there are still some missing links.
As the hub of the Pan-Canadian Proteomics Centre, the University of Victoria has conducted research that has been used to further the treatment of many conditions and diseases, including cardiovascular disease, cancer and infections.
It has also been a pillar of B.C.’s $1.6B life sciences sector, helping B.C. to be a global leader within the biomedical and life science industries.
With PacifiCan’s support, the University of Victoria Genome B.C. Proteomics Centre is taking it to the next level by implementing innovative, state of the art new technology.
The Bruker timsTOF fleX MALDI-2 mass spectrometer, the first installed in Canada, will provide molecular spatial imaging for advancements in cancer research, drug development, personalized medicine, and so much more.
$1.2 million in PacifiCan funding helped the University of Victoria Genome B.C. Proteomics Centre remain at the forefront of life sciences and biomedical research through:
- Assisting over 20 B.C. based life science businesses
- Providing Highly Qualified Personnel (HQP) advanced training to 20 experts
- Catalyzing innovative solutions to support new innovations in B.C.
